Why did WeightWatchers file for bankruptcy?
How are Trump’s tariffs impacting U.S. auto prices?
What caused Apple shares to fall amid tech shifts?
Why is the Fed holding interest rates steady?
How will U.S.-China trade talks affect markets?
What led to the Newark airport disruptions?
Why is Disney building a theme park in Abu Dhabi?
How did CrowdStrike’s 5% layoffs impact stock?
What is the impact of Trump’s AI chip export rollback?
Novo Nordisk's Weight Loss Blockbuster Faces Setback From US Compounding Surge, Forecast Trimmed
benzinga.com/general/health-care/25/05/45245367/novo-nordisks-weight-loss-blockbuster-faces-setback-from-us-compounding-surge-forecast-trimme
Novo Nordisk A/S (NYSE:NVO) slashed its 2025 sales forecast Wednesday, citing lower-than-expected penetration of its branded GLP-1 weight loss and diabetes treatments in the U.S. market due to competition from compounded versions of the drugs.
What Happened: The Danish pharmaceutical…
This story appeared on benzinga.com, 2025-05-07 07:36:19.